نتایج جستجو برای: blocker treatment

تعداد نتایج: 1407046  

Journal: :روانپزشکی و روانشناسی بالینی ایران 0
سید علی احمدی ابهری sayad ali ahmadi abhari south kargar ave., roozbeh hospital, tehran, iran, i.r..تهران،بیمارستان روزبه،خیابان کارگر جنوبی. سعید محتشم saed . mohtasham .تهران،بیمارستان روزبه،خیابان کارگر جنوبی.

purpose: the purpose of this study was to determine the effectiveness of famotidine, a h2 blocker, in the improving schizophrenic patients’ symptoms.   method: 28 chronic schizophrenic patients were randomly assigned to two groups, with each group consisting of 14 patients. one group received 20 mg of haloperidol per day and the other group was on 40 mg famotidine and 20 mg of haloperidol per d...

2010
Kenneth A Holroyd Constance K Cottrell Francis J O’Donnell Gary E Cordingley Jana B Drew Bruce W Carlson Lina Himawan

OBJECTIVE To determine if the addition of preventive drug treatment (β blocker), brief behavioural migraine management, or their combination improves the outcome of optimised acute treatment in the management of frequent migraine. DESIGN Randomised placebo controlled trial over 16 months from July 2001 to November 2005. SETTING Two outpatient sites in Ohio, USA. PARTICIPANTS 232 adults (m...

Journal: :Practica Oto-Rhino-Laryngologica 1993

2014
B.D. Eason D.M. Fine D. Leeder C. Stauthammer K. Lamb A.H. Tobias

BACKGROUND Subaortic stenosis (SAS) is one of the most common congenital cardiac defects in dogs. Severe SAS frequently is treated with a beta adrenergic receptor blocker (beta blocker), but this approach largely is empirical. OBJECTIVE To determine the influence of beta blocker treatment on survival time in dogs with severe SAS. METHODS Retrospective review of medical records of dogs diagn...

Journal: :medical journal of islamic republic of iran 0
mohammad-reza zarrindast from the department of pharmacology, faculty of medicine, tehran university of medical sciences, tehran, islamic republic of iran. yadollah khalenabi mohammad hossein pourgholami

intraperitoneal (ip) injection of bupropion (3,6, amine (4,16 mg kg•&apos;) induced dose-dependent climbing in mice. the climbing response induced by both drugs were decreased in animals pretreated either with the 0-1 antagonist sch 233<)0 or the 0-2 antagonist sulpiride. the α-adrenoceptor blocker phenoxybenzamine decreased the climbing induced by both bupropion and amphetamine, but the β-adre...

Journal: :Emergency Care Journal 2022

Bradycardia, renal failure, Atrioventricular (AV) nodal Blocker Drug Use, Shock, and Hyperkalemia (BRASH) syndrome is a clinical condition frequently seen in emergency services but with low diagnostic awareness. In cases of the syndrome, its cause was determined to be synergistic effect hyperkalemia due failure use AV blocker drugs. The common features patients diagnosed BRASH are moderately el...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید